{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:35Z","timestamp":1786119395782,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/rhu.0b013e3181c78ddc","type":"journal-article","created":{"date-parts":[[2009,12,26]],"date-time":"2009-12-26T03:20:57Z","timestamp":1261797657000},"page":"40-42","source":"Crossref","is-referenced-by-count":8,"title":["Refractory Polyarticular Gouty Arthritis as a Manifestation of Immune Reconstitution Inflammatory Syndrome"],"prefix":"10.1097","volume":"16","author":[{"given":"Peter J.","family":"Sebeny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence X.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210207","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/503903","article-title":"Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy.","volume":"42","author":"Robertson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R2-13-20210207","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semarthrit.2005.03.007","article-title":"Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease.","volume":"35","author":"Calabrese","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"R3-13-20210207","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00002030-200101050-00026","article-title":"Alopecia universalis and Graves\u2019 disease in the setting of immune restoration after highly active antiretroviral therapy.","volume":"15","author":"Sereti","year":"2001","journal-title":"AIDS"},{"key":"R5-13-20210207","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/383034","article-title":"Immune reconstitution in HIV-infected patients.","volume":"38","author":"Hirisch","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R6-13-20210207","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/dki444","article-title":"Immune reconstitution inflammatory syndrome: more answers, more questions.","volume":"57","author":"Shelburne","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R7-13-20210207","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout.","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"issue":"suppl 5","key":"R8-13-20210207","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/ajhp\/56.suppl_5.S9","article-title":"Neutrophil deficiency and dysfunction in HIV-infected patients.","volume":"56","author":"Pitrak","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"R9-13-20210207","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(05)80684-5","article-title":"Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor.","volume":"117","author":"Roilides","year":"1990","journal-title":"J Pediatr"},{"key":"R10-13-20210207","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00002030-199905280-00003","article-title":"Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients.","volume":"13","author":"Mastroianni","year":"1999","journal-title":"AIDS"},{"key":"R11-13-20210207","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature04516","article-title":"Gout associated uric acid crystals activate the NALP3 inflammosome.","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"R12-13-20210207","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout.","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R13-13-20210207","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/ard.2007.073759","article-title":"Management of treatment resistant inflammation of acute and chronic tophaceous gout with anakinra.","volume":"66","author":"McGonagle","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R14-13-20210207","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/rheumatology\/keh640","article-title":"Mechanisms of inflammation in gout.","volume":"44","author":"Dalbeth","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R15-13-20210207","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.10468","article-title":"Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches.","volume":"46","author":"Murakami","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R16-13-20210207","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2249.1999.00865.x","article-title":"IL-10 in HIV infection: increasing serum IL-10 levels with disease progression\u2013down-regulatory effect of potent anti-retroviral therapy.","volume":"116","author":"Stylianou","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"R17-13-20210207","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.1128\/JVI.00324-06","article-title":"Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons.","volume":"80","author":"Tilton","year":"2006","journal-title":"J Virol"},{"key":"R18-13-20210207","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0463.2006.apm_108.x","article-title":"IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy.","volume":"114","author":"Orsilles","year":"2006","journal-title":"APMIS"},{"key":"R19-13-20210207","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0966-842X(00)01919-3","article-title":"Hijacking and exploitation of IL-10 by intracellular pathogens.","volume":"9","author":"Redpath","year":"2001","journal-title":"Trends Microbiol"},{"key":"R20-13-20210207","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/BOR.0b013e3282f4eff5","article-title":"Refractory gout: what is it and what to do about it?","volume":"20","author":"Fels","year":"2008","journal-title":"Curr Opin Rheum"},{"key":"R21-13-20210207","first-page":"1839","article-title":"Rheumatology. 4th ed.","author":"Emmerson","year":"2008"},{"key":"R22-13-20210207","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"R23-13-20210207","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-0172(90)90070-V","article-title":"Systemic steroid therapy for acute gout: a clinical trial and review of the literature.","volume":"19","author":"Groff","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"R24-13-20210207","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1097\/01.aids.0000237374.16068.de","article-title":"High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters.","volume":"20","author":"Walker","year":"2006","journal-title":"AIDS"},{"key":"R25-13-20210207","first-page":"362","article-title":"Is ritonavir boosting associated with gout?","volume":"16","author":"Creighton","year":"2005","journal-title":"Int J STD AIDS"},{"key":"R26-13-20210207","article-title":"Bristol-Myers Squibb Company [package insert].","year":"2007"},{"key":"R27-13-20210207","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-2952(96)00693-4","article-title":"Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation.","volume":"53","author":"Tateishi","year":"1997","journal-title":"Biochem Pharmacol"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124743-201001000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:30Z","timestamp":1786039770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124743-201001000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3181c78ddc","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}